Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Shares Issued came in at $10.7 million in Q2 2026, up 4.6% YoY from $10.3 million in Q2 2025, and down 1.25% on a QoQ basis from $10.9 million in Q1 2026.
Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 9 years of Shares Issued data on file, last reported at $10.7 million in Q2 2026.
- Quarterly Shares Issued rose 4.6% year-over-year to $10.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.7 million (up 4.6% YoY) and the FY2025 annual result came in at $9.8 million, up 12.05% from the prior year.
- Shares Issued declined to $10.7 million in Q2 2026, from $10.9 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $10.9 million in Q1 2026 to a low of $5.4 million in Q1 2022.
- A 5-year average of $8.3 million and a median of $8.8 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2023 — Shares Issued surged 35.66% — and 2026, when it gained 4.6%.
- Tracing BCYC's Shares Issued over 5 years: stood at $5.9 million in 2022, then increased by 26.63% to $7.5 million in 2023, then grew by 17.13% to $8.7 million in 2024, then advanced by 12.05% to $9.8 million in 2025, then climbed by 9.62% to $10.7 million in 2026.
- The last three Shares Issued figures came in at $10.7 million (Q2 2026), $10.9 million (Q1 2026), and $9.8 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bicycle Therapeutics | 272.28 Mn | 272.28 Mn | - | 10.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.75 Mn |
| Jun 30, 2026 | 10.75 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | 10.19 Mn |
| Sep 30, 2025 | 10.19 Mn |
| Jun 30, 2025 | 607,300.00 |
| Jun 30, 2025 | 607,300.00 |
| Mar 31, 2025 | 487,200.00 |
| Mar 31, 2025 | 487,200.00 |
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 100,700.00 |
| Sep 30, 2024 | 100,700.00 |
| Jun 30, 2024 | 6.52 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.95 Mn |